Free Radical Group, The Heart Research Institute, Sydney, New South Wales, Australia ; Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia.
PLoS One. 2014 Jan 21;9(1):e86564. doi: 10.1371/journal.pone.0086564. eCollection 2014.
Diabetes is associated with elevated plasma glucose, increased reactive aldehyde formation, oxidative damage, and glycation/glycoxidation of biomolecules. Cellular detoxification of, or protection against, such modifications commonly requires NADPH-dependent reducing equivalents (e.g. GSH). We hypothesised that reactive aldehydes may modulate cellular redox status via the inhibition of NADPH-generating enzymes, resulting in decreased thiol and NADPH levels. Primary human coronary artery endothelial cells (HCAEC) were incubated with high glucose (25 mM, 24 h, 37°C), or methylglyoxal (MGO), glyoxal, or glycolaldehyde (100-500 µM, 1 h, 37°C), before quantification of intracellular thiols and NADPH-generating enzyme activities. Exposure to MGO, but not the other species examined, significantly (P<0.05) decreased total thiols (∼35%), further experiments with MGO showed significant losses of GSH (∼40%) and NADPH (∼10%); these changes did not result in an immediate loss of cell viability. Significantly decreased (∼10%) NADPH-producing enzyme activity was observed for HCAEC when glucose-6-phosphate or 2-deoxyglucose-6-phosphate were used as substrates. Cell lysate experiments showed significant MGO-dose dependent inhibition of glucose-6-phosphate-dependent enzymes and isocitrate dehydrogenase, but not malic enzyme. Analysis of intact cell or lysate proteins showed that arginine-derived hydroimidazolones were the predominant advanced glycation end-product (AGE) formed; lower levels of N(ε)-(carboxyethyl)lysine (CEL) and N(ε)-(carboxymethyl)lysine (CML) were also detected. These data support a novel mechanism by which MGO exposure results in changes in redox status in human coronary artery endothelial cells, via inhibition of NADPH-generating enzymes, with resultant changes in reduced protein thiol and GSH levels. These changes may contribute to the endothelial cell dysfunction observed in diabetes-associated atherosclerosis.
糖尿病与血浆葡萄糖升高、反应性醛形成增加、氧化损伤以及生物分子的糖化/糖基化有关。细胞对这些修饰的解毒或保护通常需要 NADPH 依赖性还原当量(例如 GSH)。我们假设反应性醛可能通过抑制 NADPH 生成酶来调节细胞氧化还原状态,从而导致巯基和 NADPH 水平降低。将原代人冠状动脉内皮细胞(HCAEC)在高葡萄糖(25 mM,24 h,37°C)或甲基乙二醛(MGO)、乙二醛或甘油醛(100-500 µM,1 h,37°C)中孵育,然后定量细胞内巯基和 NADPH 生成酶活性。暴露于 MGO 但不是其他检查的物质显著降低了总巯基(约 35%),进一步用 MGO 进行的实验表明 GSH(约 40%)和 NADPH(约 10%)明显减少;这些变化并没有导致细胞活力的立即丧失。当葡萄糖-6-磷酸或 2-脱氧葡萄糖-6-磷酸用作底物时,观察到 HCAEC 的 NADPH 生成酶活性显著降低(约 10%)。细胞裂解物实验表明,MGO 剂量依赖性地抑制葡萄糖-6-磷酸依赖性酶和异柠檬酸脱氢酶,但不抑制苹果酸酶。对完整细胞或裂解物蛋白的分析表明,精氨酸衍生的氢咪唑啉酮是形成的主要晚期糖基化终产物(AGE);还检测到较低水平的 N(ε)-(羧乙基)赖氨酸(CEL)和 N(ε)-(羧甲基)赖氨酸(CML)。这些数据支持了一种新的机制,即 MGO 暴露通过抑制 NADPH 生成酶导致人冠状动脉内皮细胞氧化还原状态发生变化,从而导致还原蛋白巯基和 GSH 水平发生变化。这些变化可能导致与糖尿病相关的动脉粥样硬化中观察到的内皮细胞功能障碍。